These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20664182)

  • 1. Downregulation of nucleostemin causes G1 cell cycle arrest via a p53-independent pathway in prostate cancer PC-3 cells.
    Liu R; Zhang Z; Xu Y
    Urol Int; 2010; 85(2):221-7. PubMed ID: 20664182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene profiling after knocking-down the expression of NS gene in prostate cancer PC-3 cells].
    Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Zhang Y; Li SZ
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):561-5. PubMed ID: 20021940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
    Spurgers KB; Coombes KR; Meyn RE; Gold DL; Logothetis CJ; Johnson TJ; McDonnell TJ
    Oncogene; 2004 Mar; 23(9):1712-23. PubMed ID: 14647426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of nucleostemin in prostate cancer and its effect on the proliferation of PC-3 cells.
    Liu RL; Zhang ZH; Zhao WM; Wang M; Qi SY; Li J; Zhang Y; Li SZ; Xu Y
    Chin Med J (Engl); 2008 Feb; 121(4):299-304. PubMed ID: 18304460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of HL-60 cells following knockdown of nucleostemin using DNA microarrays.
    Sun X; Jia Y; Wei Y; Liu S; Yue B
    Oncol Rep; 2014 Aug; 32(2):739-47. PubMed ID: 24912530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
    Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
    Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of hepatocyte nuclear factor-3alpha induces apoptosis through the upregulation and accumulation of cytoplasmic p53 in prostate cancer cells.
    Lee HJ; Chattopadhyay S; Yoon WH; Bahk JY; Kim TH; Kang HS; Lee K
    Prostate; 2010 Mar; 70(4):353-61. PubMed ID: 19866472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells.
    Guzey M; Luo J; Getzenberg RH
    J Cell Biochem; 2004 Oct; 93(2):271-85. PubMed ID: 15368355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.
    Kikugawa T; Kinugasa Y; Shiraishi K; Nanba D; Nakashiro K; Tanji N; Yokoyama M; Higashiyama S
    Prostate; 2006 Jul; 66(10):1092-9. PubMed ID: 16637071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
    Salnikow K; Costa M; Figg WD; Blagosklonny MV
    Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silvestrol regulates G2/M checkpoint genes independent of p53 activity.
    Mi Q; Kim S; Hwang BY; Su BN; Chai H; Arbieva ZH; Kinghorn AD; Swanson SM
    Anticancer Res; 2006; 26(5A):3349-56. PubMed ID: 17094452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Silencing nucleostemin expression reduces the proliferation of PC-3 cells].
    Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Zhang Y; Li SZ
    Zhonghua Nan Ke Xue; 2009 Jul; 15(7):593-8. PubMed ID: 19694370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system.
    Okamura S; Ng CC; Koyama K; Takei Y; Arakawa H; Monden M; Nakamura Y
    Oncol Res; 1999; 11(6):281-5. PubMed ID: 10691030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxazosin induces apoptosis in LNCaP prostate cancer cell line through DNA binding and DNA-dependent protein kinase down-regulation.
    Arencibia JM; Del Rio M; Bonnin A; Lopes R; Lemoine NR; López-Barahona M
    Int J Oncol; 2005 Dec; 27(6):1617-23. PubMed ID: 16273218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleostemin knocking-down causes cell cycle arrest and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells via p53 and p21Waf1/Cip1 up-regulation.
    Rahmati M; Moosavi MA; Zarghami N
    Hematology; 2014 Dec; 19(8):455-62. PubMed ID: 24628257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism.
    Wang Y; Shao C; Shi CH; Zhang L; Yue HH; Wang PF; Yang B; Zhang YT; Liu F; Qin WJ; Wang H; Shao GX
    Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
    Yu CH; Kan SF; Pu HF; Jea Chien E; Wang PS
    Cancer Sci; 2008 Dec; 99(12):2467-76. PubMed ID: 19037992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.